Lifestyle interventions reduce need for antihypertensive medication in overweight people
Researchers found that assigning overweight patients to the DASH diet and a behavioural weight management programme cut the number of patients eligible for antihypertensive medication
Lifestyle interventions to improve nutrition and exercise can cut the number of overweight and obese people who are eligible for antihypertensive medicines, according to an analysis presented at the American Heart Association Joint Hypertension 2018 Scientific Sessions in Chigago, Illinois.
Researchers studied data on 129 overweight or obese individuals aged 40–80 years old with a blood pressure reading of 130–160mmHg/80–99mmHg who were randomly assigned to follow either the DASH (Dietary Approaches to Stop Hypertension) diet; the DASH diet a behavioural weight management programme; or to continue with their normal habits.
The DASH diet places an emphasis on fruit, vegetables and wholegrains, and limits sugar and saturated fat consumption.
Before the trial, 53% of individuals across the three groups were eligible for antihypertensive treatment, according to US guidelines.
At the end of the intervention, individuals eligible for treatment fell from 51% to 23% in the DASH alone group and from 54% to 15% in the DASH weight management group. It did not change significantly in the control group (55% to 48%).
“In overweight or obese men and women with hypertension, lifestyle interventions dramatically decrease the number of individuals for whom guideline-directed antihypertensive medication is indicated,” the researchers concluded.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205529
Recommended from Pharmaceutical Press
A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.£33.00
All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.£27.00
A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.£38.00
Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.£33.00
Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.£38.00